The three opioid peptide families (endorphins, enkephalins, dynorphins) each play distinct roles in alcohol's rewarding effects, with mu and delta receptors promoting and kappa receptors opposing alcohol reward.
Receptor-specific addiction rolesMu and delta receptors drive alcohol reward while kappa receptors oppose it — each with distinct endogenous peptide mediators
What the researchers found
Mu and delta opioid receptors mediate alcohol's rewarding properties while kappa receptors oppose them, with all three endogenous opioid peptide families playing distinct roles in addiction.
Why it matters
Understanding which opioid receptors drive alcohol reward vs. aversion could enable more targeted treatments with fewer side effects than broad opioid blockade.
How the study worked
Comprehensive review of preclinical and clinical evidence on opioid receptor subtypes and their endogenous peptide ligands in alcohol reward, craving, and addiction.
What this study cannot tell us
Review article; some claims based on animal data. Individual variation in opioid system genetics affects treatment response.
How to read the evidence
Moderate evidence from a comprehensive review covering animal and clinical studies, supporting naltrexone's established clinical use.
When this study was published
Published in 1997, shortly after naltrexone's approval for alcohol dependence. The opioid-alcohol connection has been extensively validated since.
The bigger picture
This review consolidated the scientific basis for naltrexone's FDA approval for alcohol dependence and pointed toward future receptor-specific treatments.
Questions still open
- Would kappa receptor agonists reduce alcohol craving without the side effects of broad opioid blockade?
- Can genetic differences in opioid peptide production predict alcohol addiction risk?
Common questions
How does alcohol affect the opioid system?
How does naltrexone help with alcohol addiction?
Read the original research
Endogenous opioid systems and alcohol addiction.
Psychopharmacology, 129(2), 99-111
Citation
Herz, A. (1997). Endogenous opioid systems and alcohol addiction.. Psychopharmacology, 129(2), 99-111.